Published in Cancer Invest on January 01, 2004
The evolving role of radiation therapy in the management of malignant melanoma. Int J Radiat Oncol Biol Phys (2011) 1.04
Treatment of cutaneous melanoma: current approaches and future prospects. Cancer Manag Res (2010) 1.01
Future of radiation therapy for malignant melanoma in an era of newer, more effective biological agents. Onco Targets Ther (2011) 0.88
Management of melanoma brain metastases in the era of targeted therapy. J Skin Cancer (2011) 0.81
Both HDAC5 and HDAC6 are required for the proliferation and metastasis of melanoma cells. J Transl Med (2016) 0.80
Current treatment options of brain metastases and outcomes in patients with malignant melanoma. Rep Pract Oncol Radiother (2015) 0.77
RE: A comparison of survival rates for treatment of melanoma metastatic to the brain. Cancer Invest (2004) 0.75
Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med (2003) 13.99
Body-mass index and mortality among 1.46 million white adults. N Engl J Med (2010) 13.34
Transforming fusions of FGFR and TACC genes in human glioblastoma. Science (2012) 5.09
Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol (2004) 4.69
Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol (2004) 3.56
Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology (2008) 2.83
Work-related musculoskeletal disorders in physical therapists: a prospective cohort study with 1-year follow-up. Phys Ther (2008) 2.53
TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group. Lancet Oncol (2007) 2.03
Circulating 25-hydroxyvitamin D and the risk of rarer cancers: Design and methods of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol (2010) 1.95
Dynamic contrast-enhanced perfusion MR imaging measurements of endothelial permeability: differentiation between atypical and typical meningiomas. AJNR Am J Neuroradiol (2003) 1.83
Outcome of salvage total laryngectomy following organ preservation therapy: the Radiation Therapy Oncology Group trial 91-11. Arch Otolaryngol Head Neck Surg (2003) 1.76
Insulin-like growth factor-I, IGF binding protein-3, and breast cancer in young women: a comparison of risk estimates using different peptide assays. Cancer Epidemiol Biomarkers Prev (2005) 1.67
Final analysis of RTOG 9708: adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer. Gynecol Oncol (2006) 1.63
Reproducibility of serum cytokines and growth factors. Cytokine (2008) 1.61
High-grade glioma before and after treatment with radiation and Avastin: initial observations. Neuro Oncol (2008) 1.61
A clinical trial of bevacizumab, temozolomide, and radiation for newly diagnosed glioblastoma. J Neurosurg (2011) 1.52
Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women. Int J Cancer (2004) 1.52
Circulating inflammation markers and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev (2011) 1.44
Extracapsular tumor extension in cervical lymph nodes: reconciling the literature and seer data. Head Neck (2010) 1.42
Circulating 25-hydroxyvitamin D and risk of kidney cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol (2010) 1.40
Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer. Int J Cancer (2004) 1.33
The potential protective effects of taurine on coronary heart disease. Atherosclerosis (2009) 1.27
Postmenopausal levels of endogenous sex hormones and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev (2009) 1.24
Targeted deletion of the genes encoding NTH1 and NEIL1 DNA N-glycosylases reveals the existence of novel carcinogenic oxidative damage to DNA. DNA Repair (Amst) (2009) 1.24
R132H-mutation of isocitrate dehydrogenase-1 is not sufficient for HIF-1α upregulation in adult glioma. Acta Neuropathol (2010) 1.22
Feasibility of using bevacizumab with radiation therapy and temozolomide in newly diagnosed high-grade glioma. Int J Radiat Oncol Biol Phys (2008) 1.17
A pooled analysis of 12 cohort studies of dietary fat, cholesterol and egg intake and ovarian cancer. Cancer Causes Control (2006) 1.17
Prevention and management of cerebrospinal fluid leak following vestibular schwannoma surgery. Laryngoscope (2004) 1.16
Integrating epidermal growth factor receptor assay with clinical parameters improves risk classification for relapse and survival in head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys (2010) 1.16
Reliability of tumor markers, chemokines, and metastasis-related molecules in serum. Eur Cytokine Netw (2009) 1.16
Preliminary analysis of RTOG 9708: Adjuvant postoperative radiotherapy combined with cisplatin/paclitaxel chemotherapy after surgery for patients with high-risk endometrial cancer. Int J Radiat Oncol Biol Phys (2004) 1.15
Circulating cytokines and risk of B-cell non-Hodgkin lymphoma: a prospective study. Cancer Causes Control (2010) 1.14
Circulating 25-hydroxyvitamin D and risk of endometrial cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol (2010) 1.12
Phase II trial of lapatinib in adult and pediatric patients with neurofibromatosis type 2 and progressive vestibular schwannomas. Neuro Oncol (2012) 1.10
Vitamin D receptor polymorphisms and risk of epithelial ovarian cancer. Cancer Lett (2008) 1.09
Polymorphisms in XPC and ERCC2 genes, smoking and breast cancer risk. Int J Cancer (2008) 1.08
Ipilimumab in melanoma with limited brain metastases treated with stereotactic radiosurgery. Melanoma Res (2013) 1.08
Postmenopausal levels of sex hormones and risk of breast carcinoma in situ: results of a prospective study. Int J Cancer (2005) 1.03
Circulating estrogen metabolites and risk for breast cancer in premenopausal women. Cancer Epidemiol Biomarkers Prev (2009) 1.02
Pesticide product use and risk of non-Hodgkin lymphoma in women. Environ Health Perspect (2004) 1.00
Job strain in physical therapists. Phys Ther (2009) 1.00
Non-vena cava venous leiomyosarcomas: a review of the literature. Ann Surg Oncol (2012) 1.00
Cancer risk assessment using genetic panel testing: considerations for clinical application. J Genet Couns (2014) 0.98
Vemurafenib and radiation therapy in melanoma brain metastases. J Neurooncol (2013) 0.96
Cost-effectiveness of 21-gene assay in node-positive, early-stage breast cancer. Am J Manag Care (2011) 0.96
Reproducibility of serum pituitary hormones in women. Cancer Epidemiol Biomarkers Prev (2008) 0.95
Temporal reliability of cytokines and growth factors in EDTA plasma. BMC Res Notes (2010) 0.95
Circulating levels of 25-hydroxyvitamin D and risk of breast cancer: a nested case-control study. Breast Cancer Res (2013) 0.95
Polymorphisms in RAD51, XRCC2, and XRCC3 are not related to breast cancer risk. Cancer Epidemiol Biomarkers Prev (2008) 0.95
Fruits and vegetables and ovarian cancer risk in a pooled analysis of 12 cohort studies. Cancer Epidemiol Biomarkers Prev (2005) 0.92
Selected polymorphisms in sex hormone-related genes, circulating sex hormones and risk of endometrial cancer. Cancer Epidemiol (2012) 0.92
A multicenter, single-blind, prospective randomized trial to evaluate the safety of a polyethylene glycol hydrogel (Duraseal Dural Sealant System) as a dural sealant in cranial surgery. World Neurosurg (2011) 0.91
Phase II study of everolimus in children and adults with neurofibromatosis type 2 and progressive vestibular schwannomas. Neuro Oncol (2013) 0.90
Auditory brainstem implantation in patients with neurofibromatosis type 2. Laryngoscope (2004) 0.90
Genetic variants associated with breast cancer risk for Ashkenazi Jewish women with strong family histories but no identifiable BRCA1/2 mutation. Hum Genet (2013) 0.90
Reliability of serum assays of iron status in postmenopausal women. Ann Epidemiol (2006) 0.89
Gamma Knife radiosurgery for the management of nonfunctioning pituitary adenomas: a multicenter study. J Neurosurg (2013) 0.89
Factors associated with inflammation markers, a cross-sectional analysis. Cytokine (2011) 0.89
Endogenous hormones and coronary heart disease in postmenopausal women. Atherosclerosis (2011) 0.89
Premenopausal serum androgens and breast cancer risk: a nested case-control study. Breast Cancer Res (2012) 0.89
Retrolabyrinthine craniectomy: the unsung hero of skull base surgery. Skull Base (2004) 0.88
IGF-I, IGFBP-3 and breast cancer in young women: a pooled re-analysis of three prospective studies. Eur J Cancer Prev (2005) 0.87
Efficacy of gamma knife radiosurgery for small-volume recurrent malignant gliomas after initial radical resection. World Neurosurg (2011) 0.87
Use of anti-inflammatory and non-narcotic analgesic drugs and risk of non-Hodgkin's lymphoma (NHL) (United States). Cancer Causes Control (2002) 0.87
Circulating vitamin d and risk of epithelial ovarian cancer. J Oncol (2009) 0.87
Phase I study of bryostatin 1, a protein kinase C modulator, preceding cisplatin in patients with refractory non-hematologic tumors. Cancer Chemother Pharmacol (2009) 0.87
Management of Spitz nevi: a survey of dermatologists in the United States. J Am Acad Dermatol (2002) 0.87
Results of surgical resection for progression of brain metastases previously treated by gamma knife radiosurgery. Neurosurgery (2006) 0.86
Genetic variants in hormone-related genes and risk of breast cancer. PLoS One (2013) 0.85
History of antibiotic use and risk of non-Hodgkin's lymphoma (NHL). Int J Cancer (2003) 0.84
Personal and occupational exposure to organic solvents and risk of non-Hodgkin's lymphoma (NHL) in women (United States). Cancer Causes Control (2005) 0.84
Importance of MR technique for stereotactic radiosurgery. Neuro Oncol (2003) 0.84
Phase III study of radiation therapy with or without cis-platinum in patients with unresectable squamous or undifferentiated carcinoma of the head and neck: an intergroup trial of the Eastern Cooperative Oncology Group (E2382). Int J Radiat Oncol Biol Phys (2010) 0.83
Glioma vascularity correlates with reduced patient survival and increased malignancy. Surg Neurol (2009) 0.83
Feasibility and cardiac safety of pegylated liposomal doxorubicin plus trastuzumab in heavily pretreated patients with recurrent HER2-overexpressing metastatic breast cancer. Clin Breast Cancer (2007) 0.82
A panoramic view of the skull base: systematic review of open and endoscopic endonasal approaches to four tumors. Pituitary (2014) 0.81
Auditory rehabilitation of patients with neurofibromatosis Type 2 by using cochlear implants. J Neurosurg (2011) 0.81
Circulating prolactin levels and risk of epithelial ovarian cancer. Cancer Causes Control (2013) 0.81
Neurological complications and symptom resolution following Gamma Knife surgery for brain metastases 2 cm or smaller in relation to eloquent cortices. J Neurosurg (2010) 0.81
Incidence, timing, and treatment of new brain metastases after Gamma Knife surgery for limited brain disease: the case for reducing the use of whole-brain radiation therapy. J Neurosurg (2011) 0.81
Challenging the current paradigm of melanoma progression: brain metastasis as isolated first visceral site. Neuro Oncol (2012) 0.81
Phase II trial of dacarbazine and thalidomide for the treatment of metastatic melanoma. Chemotherapy (2009) 0.81
Resection of parietal lobe gliomas: incidence and evolution of neurological deficits in 28 consecutive patients correlated to the location and morphological characteristics of the tumor. J Neurosurg (2005) 0.81
Re: C-reactive protein and risk of breast cancer. J Natl Cancer Inst (2008) 0.80
Circulating enterolactone and risk of endometrial cancer. Int J Cancer (2006) 0.80
Posterior fossa meningiomas presenting with Ménière's-like symptoms: case report. Neurosurgery (2008) 0.80
Local control of newly diagnosed and distally recurrent, low-volume brain metastases with fixed-dose (20 gy) gamma knife radiosurgery. Neurosurgery (2011) 0.80
Cranial nerve preservation in surgery for large acoustic neuromas. Skull Base (2004) 0.80
Development and characterization of a clinically relevant mouse model of melanoma brain metastasis. Pigment Cell Melanoma Res (2013) 0.79
Temporal reproducibility of taurine measurements in frozen serum of healthy postmenopausal women. Br J Nutr (2010) 0.79
Management of surgical complications and failures in acoustic neuroma surgery. Otolaryngol Clin North Am (2012) 0.78
Dynamic susceptibility contrast-enhanced perfusion and conventional MR imaging findings for adult patients with cerebral primitive neuroectodermal tumors. AJNR Am J Neuroradiol (2004) 0.78
Involved field radiation therapy after surgical resection of solitary brain metastases--mature results. Neuro Oncol (2013) 0.78
Serum taurine and risk of coronary heart disease: a prospective, nested case-control study. Eur J Nutr (2012) 0.78
Small vestibular schwannomas with no hearing: comparison of functional outcomes in stereotactic radiosurgery and microsurgery. Laryngoscope (2008) 0.77
Role of HER2 status in the treatment for brain metastases arising from breast cancer with stereotactic radiosurgery. Med Oncol (2014) 0.76
Amusia following resection of a Heschl gyrus glioma. Case report. J Neurosurg (2003) 0.76
Temporal bone histopathology case of the month: Malignant peripheral nerve sheath tumor arising within vestibular schwannoma. Otol Neurotol (2012) 0.76
Efficacy of clevidipine in controlling perioperative hypertension in neurosurgical patients: initial single-center experience. J Neurosurg Anesthesiol (2010) 0.76
Feasibility of using administrative claims data for cost-effectiveness analysis of a clinical trial. J Med Econ (2008) 0.75